作者的详细信息

Baranov, Igor I.

期 栏目 标题 文件
编号 4 (2016) Articles Medically induced abortion at 12 to 22 weeks gestation: Indications, methods, and results
编号 7 (2017) Articles Lotus I: A Phase III randomized controlled trial of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization, with focus on the Russian subpopulation
编号 12 (2018) Articles Multicomponent therapy in patients with pelvic inflammatory diseases
编号 1 (2020) Articles Premature birth: past restrictions and new opportunities
编号 12 (2019) Articles Noninvasive prenatal testing in Russia: a population study
编号 12 (2019) Articles Metabolomic profile in pregnant women with fetal growth restriction
编号 6 (2020) Articles Iron deficiency states during pregnancy: prevention and treatment
编号 7 (2020) Articles The use of a new topical combination drug (metronidazole + chloramphenicol + natamycin + hydrocortisone acetate) for the treatment of vaginitides of various etiologies
编号 3 (2020) Articles Use of placental therapy in the correction of functional impairments in women: investigations and clinical practice
编号 1 (2021) Articles INITIAL RESULTS OF CLINICAL APPLICATION OF MESENCHYMAL STROMAL STEM CELL-DERIVED EXTRACELLULAR MICROVESICLES AFTER ABDOMINAL DELIVERY
编号 6 (2021) Articles Risk factors for infectious and inflammatory diseases of the lower genital tract in women using contraception
编号 9 (2021) Articles Current understanding of the relationship between gut and vaginal microbiotas
编号 4 (2022) Articles Feasibility of delivery in patients receiving mesenchymal stromal cell-derived extracellular microvesicles during the previous caesarean section
编号 8 (2023) Clinical Notes Resolution of the Council of Experts in obstetrics-gynecology, dermatovenerology, gastroenterology and microbiology "Principles of intimate hygiene in healthy women and in vulvar diseases"
编号 9 (2023) Original Articles Delivery of patients with a uterine scar who have undergone cell technology in a previous caesarean section
编号 12 (2023) Original Articles Paradigm shift in pharmacotherapy for late-onset preeclampsia: advantages of two-component antihypertensive therapy compared to monotherapy based on analysis of vasoactive status data in pregnant women
编号 11 (2023) Reviews Systematic review of the efficacy and safety of nifuratel for women with diseases accompanied by pathological discharge from the genital tract
编号 11 (2023) Original Articles Pathogenetic rationale for the ineffectiveness of antihypertensive therapy based on vasoactive status analysis in patients with early-onset preeclampsia PDF
(Rus)
##common.cookie##